Bio-Rad

Bio-Rad, founded in 1952, is a prominent global leader in the test and measurement equipment and manufacturing sectors. The company specializes in developing, manufacturing, and marketing innovative products for life science research and clinical diagnostic markets. Their extensive portfolio includes advanced solutions such as PCR systems, automated diagnostic platforms, and state-of-the-art software for data management. By providing high-quality reagents, imaging systems, and chromatography media, Bio-Rad supports the scientific community in complex research and clinical laboratory environments.

Operating with a robust workforce of 5,000-10,000 employees, Bio-Rad maintains a significant international presence across 37 locations. The company’s operational footprint is anchored by its primary facility in Hercules, California. Learn about Bio-Rad's global headquarters for more information regarding their geographic reach and infrastructure. Their commitment to technological advancement is reflected in their diverse product offerings, which range from benchtop laboratory equipment to large-scale bioprocess solutions, ensuring they remain a critical partner for laboratories worldwide.

Listed on the NYSE under the ticker BIO, the company generates annual revenue of $2.6B and competes with major industry players such as Beckman Coulter Life Sciences, Illumina, and Agilent Technologies. Bio-Rad’s market strategy focuses on delivering reliable, high-performance tools that facilitate rapid discovery and accurate diagnostic results. Meet Bio-Rad's team to gain insights into their leadership and organizational structure. Through continuous innovation in fields like digital imaging, fluorescence detection, and cell culture, Bio-Rad sustains its competitive edge in the global life science and diagnostic landscape.